US Stock MarketDetailed Quotes

Biomarin Pharmaceutical (BMRN)

Watchlist
  • 53.550
  • +0.670+1.27%
Close May 13 16:00 ET
  • 53.150
  • -0.400-0.75%
Pre 08:55 ET
10.35BMarket Cap38.53P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomarin Pharmaceutical (BMRN) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Voxzogo219.88M28.70%
Vimizim210.2M27.43%
Naglazyme130.07M16.98%
Palynziq89.56M11.69%
Brineura47.1M6.15%
ALDURAZYME36.74M4.80%
Kuvan23.88M3.12%
Royalty and other revenues6.13M0.80%
ROCTAVIAN2.64M0.34%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States1.1B34.30%
Europe874.33M27.14%
Rest of world544.47M16.90%
Latin America435.48M13.52%
Aldurazyme net product revenues marketed by Sanofi208.51M6.47%
Royalty and other revenues53.49M1.66%
View all
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -